Similar documents
抜管基準(翻訳)

The Lancet NPPV July18, 2009 Non-invasive ventilation in acute respiratory failure ( Review)The Lancet, vol. 374, July 18, 2009 H22.9 The Lancet 2009

REM Rapid Eye Movement REM Zzz Non-REM



Key words ALS respiratory failure ventilation tracheostomy music therapy Spinal Surgery ALS ALS ALS 1 ALS ALS Fig


ROCKY NOTE 心不全患者 (+ チェーンストークス呼吸を伴う閉塞性睡眠時無呼吸 ) に対する ASV(adaptive servo-ventilation) の効果 (110406) 心不全 + 睡眠時

Microsoft Word - 「閉塞性睡眠時無呼吸症候群に対する口腔内装置に関する診療ガイドライン」

Table 1 Classification of degree of activity modified based on The Judgment Standard of ADL Independency (Ministry of Health and Welfare)


21-07_後藤論文.smd

medicaljournal8.pdf


終末期の呼吸困難症状への対応*松坂最終修正


神経


/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1

2

耳鼻咽喉科の診療に関連した味覚障害

Nasal Intermittent Positive Pressure Ventilation (NIPPV), Chest Negative Pressure Ventilation (CNPV), Chronic Respiratory Failure, Long Term Domicilia

C/NC : committed/noncommitted

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

食道がん化学放射線療法後のsalvage手術

人工呼吸 Jpn J Respir Care 2018;35: 短 報 神経筋疾患におけるマウスピース専用モードを用いた覚醒時の NPPV 高田学 竹内伸太郎 石川悠加 キーワード : 神経筋疾患, 非侵襲的陽圧換気療法, マウスピース Ⅰ. はじめに Table 1 Age, dis

または Type 3 PM を用いる 脳波記録の誘導数が睡眠ポリグラフ検査と同等であっても 検査室外で非監視下 ( アテンドなし ) に行う場合は Type 2 PM 検査とし アテンドによる睡眠ポリグラフ検査 (Type 1) とは区別する Type 3 PM では気流 呼吸努力 酸素飽和度の連続

第61巻5・6号(12月号)/特集1頁目(本刷)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

慢性膵炎


drop while sleeping, we can recognize the alarm and help emergency at hospital. We believe that the SpO2 monitoring system is useful for appropriate m

272 日本呼吸ケア リハビリテーション学会誌第 22 巻第 3 号 表 1 Variables Value Age, yr Sex Male 81 Female 12 Height, cm Body weight, kg 6

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

動くレントゲン

Fig Table 1 SCA3 Machado Joseph disease MJD SCA6 SCA31 Dentate rubro pallido luysian atrophy DRPLA SCA2 SCA1 Ataxin 3 Calcium channel

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)

untitled

離脱困難に対する換気モード

2018神奈川ALS

324 日本呼吸ケア リハビリテーション学会誌第 22 巻第 3 号 7 CO V 4 E 運動療法の強度と運動処方 FrequencyIntensity TimeTypeFITT 1, , 5 COPD 15 high-intensity low


臨床神経45-1.indb


118 Dementia Japan Vol. 31 No. 1 January 2017 表 1. DLB に対して mect を行った先行研究 Rasmussen K 2003 USA Japan Japan Japan Japan 1 2

untitled

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo


& Herzel, 1998;, LRS V O Bernasconi & Kohl, 1993; Garlando et al., 1985 Rassler & Kohl, 1996; van Alphen & Duffin, 1994 CLS VO Udo et al., 1990 LRS V



_’£”R‡Ù‡©

J. Smooth Muscle Res. (Jap. Section) 5: J-59--J-67, 2001 URODYNAMIC STUDY IN DIAGNOSIS OF DIABETIC DYSURIA Minoru SATO First Department of Urology, To


Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

b. OSAS 45 MRI 3 8 AHI 15/h OSAS 173 AHI 5/h 19 MRI 9 II movement disorders 1. Parkinson PD PD PD rapid eye movement sleep behavior disorder RBD

Core Ethics Vol. : - NICU : : - A B C D


65-6 小泉・谷所・野村・楠本.pwd

JHN Journal Club 手稲渓仁会病院

1 FEV1.0 FEV % NIH FEV % FEV1.0 50% FEV1.0 cyanosis PaO2 PaCO2 PaO2 PaCO2 40mmHg FEV1.0 25%

13●53頁●6-7▲院内感染対策▲.ppt

56: Hands-on 4 Meet the Expert.

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

indd

日本皮膚科学会雑誌第121巻第14号

untitled

mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD





06呼特Dr櫻井 滋=Ko552


CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A

ONO L 0.03mg/kg/min 1min 0.01mg/kg/min 10min M 0.03mg/kg/min 1min 0.02mg/kg/min 10min H 0.06mg/kg/min 1min 0.04mg/kg/min 10min 3 1) LSD p=0.000

Vol.0 No. 0 図 Montreal Cognitive AssessmentMoCA orientation visuospatial attention orientation 4 visuospatial executive MMSE MoCA language language me

Fig. 1 Chest X-ray on admission, with infiltrative shadow in the right upper lung field. Fig. 2 Chest CT scan shows an infiltrative shadow, multiple b

八戸大学紀要_45_表1pdf

606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

Parkinson disease : ,

GB 3rd edition final.ppt

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c

‹Àfi¡‚¾”O/…_…C…W…F…X…g/01-01

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

老年医学update

1. 1) Gross NJ; Co E; Skorodin MS. Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison with that in normal subjects. Chest 19

_02.indd

2 251 Barrera, 1986; Barrera, e.g., Gottlieb, 1985 Wethington & Kessler 1986 r Cohen & Wills,

東洋医学雑誌

Barthel Index

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004

164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10

.K.C.h...C...ren

人工呼吸第 2 巻第 号 Web 版 [ 公開日 : 25 年 4 月 6 日 ] dystrophy:fcmd) 例 強直性脊柱症候群 (rigid spine syndrome) 例であった 調査項目は NPPV 使用時間 使用しているインターフェイスの種類 そのインターフェイスを選択した理由

Transcription:

標準的神経治療 : 重症神経難病の呼吸ケア 呼吸管理とリハビリテーション

amyotrophic lateral sclerosis ALS Duchenne1984 1984 18.4 200431.1 1 ALS quality of life QOL ALS 2003 5ALS medical engineer ME QOL 1 Duchenne muscular dystrophy 51 : 743 749, 2011 2013 3 15 Vol. 30 No. 2 2013 193

I II III IV V Vol. 30 No. 2 2013 194

Vol. 30 No. 2 2013 195 I 1 a b 2 a b 3 a b 4 a b 5 a b c 6 a b VAP c d e II 1 2 3 4 5 6 ADL III 1 a b c 2 anppv b TPPV 3 a b IV 1 a b c d e REM RBD 2 3 a b c d V 1 2 3NPPV 4TPPV 5

I amyo trophic lateral sclerosis ALS multiple system atrophy MSA 1. 1 Fig. 1 a. ph ph Fig. 1 b. 2. 2 Fig. 2 a. 5 Fig. 2 Vol. 30 No. 2 2013 196

b. Fig. 3 4 MSA 3. a. predicted forced vital capacity FVC predicted vital capacity 50 ALS 3 maximum inspiratory pressure MIP 60cmH2O maximum expiratory pressure MEP MIP peak cough flow PCF 180l/min 270l/min 3 b. polysomnography PSG EEG EOG EMG ECG SPO2 PtCO2 Fig. 3 4. 4 a. non invasive ventilation NIV non invasive positive airway pressure ventilation NPPV NIV NIV MSA continuous positive airway pressure CPAP MSA 5 b. tracheostomy intermit tent positive pressure ventilation TPPV tracheal ventilation TV invasive intermittent positive pres Vol. 30 No. 2 2013 197

Fig. 4 sure ventilation IPPV NPPV NPPV 24 5. a. 6 Fig. 4 squeezing mechanical assisted coughing MAC 2010 1800 / VC50 PCF 270l/min PCF 160l/min MAC 20cmH2O/ 20cmH2O 1.53.0 Vol. 30 No. 2 2013 198

1.53 01 40cmH2O/ 40cmH2O 5 b. ALS c. 7 Fig. 5 2010 SU1 W SUCTION SU1 W SUCTION 6. 8 a. mechanical in exsufflator positive endexpiratory pressure PEEP 95 90 b. ventilator associated pneumonia VAP TPPV VAP Fig. 5 SU1 W SUCTION 20 30cmH2O chronic obstructive pulmonary disease COPD TPPV ALS TV 600ml 102 high volume low pressure cuffs HVLP 2 c. ALS ALS MSA d. 9 Fig. 6 Vol. 30 No. 2 2013 199

ALS Fig. 6 e. 1 51 : 189 194, 2003 2 NEW 2, p201 205 3 2 QOL 2011 3p12 13 4 ALS J Clin Rehabil 19 : 73 78, 2010 5 / MSA2 5 : 11 13, 2010 6 MAC 7 16 No.4 : 63 65, 2010 8 15 No.11 : 7 12, 2010 9 ALS. 16 No.7 : 33 36, 2010 Vol. 30 No. 2 2013 200

II / 1 1. activity of daily living ADL 2, 3 ADL 2. ADL 3. Duchenne 4, 5 6 noninva sive positive pressure ventilation NPPV NPPV 7 1 8 130ml 9 4. Bach 10 maximum insufflation capacity MIC MIC 500mlNPPV MICMIC MIC 11 MIC air stacking1 3 Air stacking 2,000ml Vol. 30 No. 2 2013 201

12 5. 3 cough peak flow CPF 13 CPF 160l/ 270l/ CPF CPF 270l/ CPF 14 mechanical insufflation exsufflation MI E 15, 16 30 40cmH2O 2010 22 6 ADL ADL ADL 1 / 40 : 536 544, 2002 2 2003 3 2007 4 Padula CA, Yeaw E : Inspiratory muscle training : integrative review of use in conditions other than COPD. Res Theory Nurs Pract 21 : 98 118, 2007 5 McCool FD, Tzelepis GE : Inspiratory muscle training in the patient with neuromuscular disease. Phys Ther 75 : 1006 1014, 1995 6 American Thoracic Society Consensus Statement : Respirato ry care of the patient with Ducheene muscular dystrophy. Am J Respir Crit Care Med 170 : 456 465, 2004 7 NPPV JJN 832008 8 Maltais F : Glossopharyngeal breathing. Am J Respir Crit Care Med 184 : 381, 2011 9 Bach JR, Bianchi C, Vidigal Lopes M et al : Lung inflation by glossopharyngeal breathing and air stacking in Duchenne muscular dystrophy. Am J Phys Med Rehabil 86 : 295 300, 2007 10 Bach JR : Conventional approaches to managing neuromus cular ventilatory failure. In Bach JR, editor. Pulmonary reha bilitation, Philadelphia, Hanley & Belfus, 1996, p285 301 11 Kang SW, Bach JR : Maximum insufflation capacity. Chest 118 : 61 65, 2000 12 Therapeutic Research 37 40, 2004 13 Bianchi C, Baiardi P : Cough peak flows : standard values for children and adolescents. Am J Phys Med Rehabil 87 : 461 467, 2008 14 Ishikawa Y, Bach JR, Komaroff E et al : Cough augmentation in Duchenne muscular dystrophy. Am J Phys Med Rehabil 87 : 726 730, 2008 15 Bach JR : Mechanical insufflation exsufflation. Comparison of peak expiratory flows with manually assisted and unassist ed coughing techniques.chest 104 : 1553 1562, 1993 16 Homnick DN : Mechanical insufflation exsufflation for airway mucus clearance. Respir Care 52 :1296 1305, 2007 Vol. 30 No. 2 2013 202

III amyotrophic lateral sclerosis ALS ALS ALS 1. a. video endoscopic examination of swallowing VE video fluoro scopic examination of swallowing VF 30 VC 50Class IVb1 Class V 1 5 6 Class V 2410ml 2010 Fig. 1 SU1 7 b. 8 Fig. 1a Fig. 1b Vol. 30 No. 2 2013 203

Fig. 2 Fig. 3 Fig. 4 RTX c. PCF 270l/min mechanical insufflations exsufflation MI Ecough assist Fig. 2 Class III 4 20cmH2O 20cmH2O 30 40cmH2O30 40cmH2O Class V 2010 2012 NPPV 1,8001 8,000 / C170 9 Intrapulmonary percussive ventilator IPV Percussionaire Fig. 3 30 40psi 20 25psi 10 10 151 1 2 RTX Fig. 4 Vol. 30 No. 2 2013 204

Table 1 ALS Fig. 5 Smart Vest 11 high frequency chest wall oscilla tion HFCWOSmart Vest Fig. 5 HFCWO 2Class III studies with conflicting results 3 2. CO2 tracheo stomy positive pressure ventilation TPPV noninvasive positive pressure ventilation NPPV NPPV Class I quality of life QOL Class IIITPPV QOL Class III 3 a. NPPV NPPV NPPV NPPV NPPV 1 4, 12 14 NPPV NPPV NPPV NPPV National Association for Medical Direction of Respiratory Care NAMDRC1 PaO2 45 2SpO2 8853 FVC 50 60cmH2O Class III ALS Table 1 1, 4 sniff nasal pressure SNP40cmH2O maxi mal inspiratory pressure MIP60cmH2O 3 SNP 10cmH2O 15 NPPV VC Table 1 NPPV NPPV NPPV Vol. 30 No. 2 2013 205

NPPV IPAP6 8 EPAP 2 4 16 NPPV b. TPPV TPPV 14, 15 NPPV TPPV 17 QOL 3. a. 2012 4 b. ALS ALS 1 ALS 21 : 127 137, 2004 2 ALS2002 42 678 719, 2002 3 Miller RG, Jackson CE, Kasarskis EJ et al : Practice parame ter update : The care of the patient with amyotrophic lateral sclerosis : Drug, nutritional, and respiratory therapies an evi dence based review. Report of the Quality Standards Sub committee of the American Academy of Neurology. Neurology 73 : 1218 1226, 2009 4 The EFNS Task Force on Diagnosis and Management of Amyo trophic Lateral Sclerosis : Andersen PM, Abrahams S, Borasio GD et al : EFNS guidelines on the Clinicall Management of Amyotrophic Lateral Sclerosis MALSrevised report of an EFNS task force. Eur J Neurology 19 : 360 375, 2012 5 NPPV QOL ALS 2008 3 6 Quality of Life, QOL 21 2010, p49 50 7 http://www3.coara.or.jp/ makoty/als/autosuc_manual_ 2010/autosuc_manual_01.htm 8 14 : 9 11, 2008 9 16 : 4 6, 2010 10 Quality of Life QOL 21 2010, p47 48 11 27 : 30 33, 2010 12 ALS 22 : 741 745, 2005 13 ALS 12 : 23 26, 2006 14 2011 p63 84 15 Kamide N, Ogino M, Yamashina N et al : Sniff nasal inspirato ry pressure in healthy Japanese subjects : mean values and lower limits of normal. Respiration 77 : 58 62, 2009. Epub 2008 Oct 28 16 2011 p49 58 17 Kitamura E, Ogino M : Occurrence of cholelithiasis and chole cystitis in amyotrophic lateral sclerosis patients with long term tracheostomy invasive ventilation. Intern Med 50 : 2291 2295, 2011 Epub 2011 Oct 15 Vol. 30 No. 2 2013 206

IV multiple system atrophy MSA olivopontocerebel lar atrophy OPCA striatonigral degenera tion SND Shy Drager Shy Drager syndrome SDS OPCA MSA synuclein alpha synuclein positive glial cytoplasmic inclu sions synuclein MSA 1, 2 3 OPCA SND SDS 4 MSA P MSA C 5 MSA 6 Parkinson MSA levodopa MSA 1. MSA stridor sleep apnea syndrome SASMSA REM REM sleep behaviour disorder RBD 90.5 100 7 a. MSASDS 8 MSA 13 69 9, 10 MSA 11 MSA 12 MSA 13 MSA35 41 14 3 MSA P 6 MSA 15 b. MSA SAS obstructive sleep apnea syndrome OSAS central sleep apnea syndrome CSAS SAS 101 MSAOSAS 15 37 10, 16 OSAS polysomnography PSG 10 5 / 5010 17 MSAOSAS SDS MSA laryngospasm 18 Gilman 2008 5 probable MSA 21 PSG 19 PSG apnea hypopnea index AHI slow wave stage III IVREM 45 9/20 continuous posi tive airway pressure CPAP Vol. 30 No. 2 2013 207

AaDO2 AHI PSG MSA PSGAHI MSA c. 6 d. MSA 8 OPCA SND e. REM REM sleep behavior disorder RBD MSA RBD RBD Parkinson REM MSAREM REM RBD GABA REM ongaba REM off 7 RBD MSA 2. 6 PSG 3. a. MSA quality of life MSA 20 probable MSA 4510 7 6 21 2 non invasive positive airway pressure ventilation NPPV 2 21 17 CPAPCPAP MSACPAP 12, 22 5 10cm CPAP biphasic positive airway pressure BiPAP 23 12 MSA 24 botulinum toxin 13, 25, 26 botu linum toxin Baclofen chlordiazepoxide benzodi azepine 17, 27 b. NPPV CPAP CPAP BiPAP CPAP BiPAP 28 botulinum toxin 6, 26 CPAPBiPAP 15 Shimohata CPAP 19 c. MSA 29 face mask CPAPMSA 22 d. 90 30 ACE 30 Vol. 30 No. 2 2013 208

17 1 Papp MI, Kahn JE, Lantos PL : Clial cytoplasmic inclusions in the CNS of patients with multiple system atrophy stria tonigral degeneration, olivo pontocerebellar atrophy and Shy Drager syndrome. J Neurol Sci 94 : 79 100, 1989 2 Yoshida M, Sone M : Mechanism of neuronal degeneration of multiple system atrophy. Brain Nerve 61 : 1051 1060, 2009 3 Benarroch EE,Schmeichel AM, Low PA et al : Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. Brain 130 : 469 475, 2007 4 Wenning GK, Ben Shlomo Y, Magalhaes M et al : Clinical features and natural history of multiple system atrophy : an analysis of 100 cases. Brain 117 : 835 845, 1994 5 Gilman S, Wenning GK, Low PA et al : Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71 : 670 676, 2008 6 Wujtewicz MA, Chwojnicki K, Owczuk R et al : Laryngeal dystonia in the course of multiple system atrophy : a cause of postoperative respiratory insufficiency. Neurol Sci Nov 6 : published online, 2011 7 Raggi A, Ferri R : Sleep disorders in neurodegenerative diseases. Eur J Neurol 17 : 1326 1338, 2010 8 Shy Drager 27 II 1999 p258 261 9 Yamaguchi M, Arai K, Asahina M et al : Laryngeal stridor in multiple system atrophy. Eur Neurol 49 : 154 159, 2003 10 Ghorayeb I, Bioulac B, Tison F : Sleep disorders in multiple system atrophy. J Neural Transm 112 : 1669 1675, 2005 11 Bannister R, Gibson W, Michaels L et al : Laryngeal abductor paralysis in multiple system atrophy. A report on three necropsied cases, with observations on the laryngeal muscled and the nuclei ambigui. Brain 104 : 351 368, 1981 12 Shiba K, Isono S, Nakazawa K : Paradoxical vocal cord motion : a review focused on multiple system atrophy. Aunis Nasus Larynx 34 : 443 452, 2007 13 Merlo IM, Occhini A, Pacchetti C et al : Not paralysis, but dys tonia causes stridor in multiple system atrophy. Neurology 58 : 649 652, 2002 14 Boesch SM, Wenning GK, Ransmayr G et al : Dystonia in multiple system atrophy. J Neurol Neurosurg Osychiatry 72 : 300 303, 2002 15 Blumin JH, Berke GS : Bilateral vocal fold paresis and multi ple system atrophy. Arc Otolaryngol Head Neck Surg 128 : 1404 1407, 2002 16 Vetrugno R, Provini F, Cortelli P et al : Sleep disorders in multiple system atrophy. A correlative video polysomno graphic study. Sleep Med 5 : 21 30, 2004 17 Mehenna R, Jankovic J : Respiratory problems in neurologic movement disorders. Parkinsonism and Related Disorders 16 : 628 638, 2010 18 Williams A, Hanson D, Calne DB : Vocal cord paralysis in the Shy Drager syndrome. J Neurol Neurosurg Psychiatry 42 : 151 153, 1979 19 Shimohata T, Shinoda H, Nakayama H et al : Daytime hypox emia, sleep disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 64 : 856 861, 2007 20 Sant Ambrogio FB, Mathew OP, Clark WD et al : Laryngeal influences on breathing pattern and posterior cricoarytenoid muscle activity. J Appl Physiol 58 : 1298 1304, 1985 21 Shimohata T, Ozawa T, Nakayama H et al : Frequency of noc tural sudden death in patients with multiple system atrophy. J Neurol 255 : 1484 1485, 2008 22 Kuźniar TJ, Morgenthaler TI, Prakash UB et al : Effects of continuous positive airway pressure on stridor in multiple system atrophy sleep laryngoscopy. J Clin Sleep Med 5 : 65 67, 2009 23 Nonaka M, Imai T, Shintani T et al : Non invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci 247 : 53 58, 2006 24 Jin K, Okabe S, Chida K et al : Tracheostomy can fatally exac erbate sleep disordered breathung in multiple system atro phy. Neurology 68 : 1618 1621, 2007 25 Marion MH, Klap P, Perrin A et al : Stridor and focal laryngeal dystonia. Lancet 339 : 457 458, 1992 26 Biltzer A, Brin MF : Laryngeal dystonia: a series with botuli num toxin therapy. Mov Disoed 22 : 673 678, 2007 27 Mariotti J, Fasano A, Contarino MF et al : Management of status dystonicus : our experience and review of the litera ture. Mov Disord 22 : 963 968, 2007 28 Holty JE, Guilleminault C : Surgical options for the treat ment of obstructive sleep apnea. Med Clin North Am 94 : 479 515, 2010 29 Malinovsky JM, Cozian A, Rivault O : Spinal anesthesia for transurethral prostatectomy in a patient with multiple system atrophy. Letter to the editor. Can J Anaesth 50 : 962 963, 2003 30 2 14 : 11 14, 2009 Vol. 30 No. 2 2013 209

V Duchenne Duchenne muscular dystrophy DMD DMD DMD tracheo stomy invasive positive pressure ventilation TPPV non invasive positive pressure ventilation NPPV intrapulmonary percussive ventilator IPV high frequency chest wall oscillation HFCWO mechanical assisted cough: MAC randomized control study 1, 2 3 1. DMD 10 Table 1 SpO2 VC maximum insufflation capacity MIC maximam inspiratory pressure MIP maximum expiratory pressure MEPcough peak flow CPF 2. DMD MIC CPF MIC MIC Table 1 Table 2 NPPV PaCO2 45mmHg 92mmHg ph 7.10 2 squeezingcpf DMD 3. noninvasive positive airway pressure ventilation NPPV DMD NPPV NPPV 2 inspiratory positive air pressure IPAP expiratory positive air pressure EPAP2 BiPAP bi level positive air pressure DMDNPPV1991 4 NPPV DMD NPPV Table 2 5 6 NPPV Vol. 30 No. 2 2013 210

Table 3 CPF 270l/min 270l/min 160l/min Fig. 1 HP NPPV NPPV IPAP 8cmH2O 10cmH2OIPAP 20cmH2O EPAP NPPV 4cmH2O breath per minute BPM IPPV BPM BPM DMD Fig. 1 DMD 30NPPV 7, 8 NPPV 9 150NPPV 10 4. tracheostomy positive airway pressure ventilation TPPV DMDALS TPPV DMD TPPV DMD NPPVTPPV Fig. 2 MAC TPPV NPPV 11 TPPV 12 TPPV DMD 13 5. DMDCPFTable 3CPF 270l/min 160l/min 14 21 MAC2 IPV HFCWO MAC Fig. 22010 4 20cmH2O40cmH2O 20cmH2O40cmH2O CPF 180l/min 15 60/ 60cmH2O Vol. 30 No. 2 2013 211

Fig. 3 IPV HFCWO 16 IPV critical opening pressure HFCWOIPV IPV HFCWO Fig. 3IPV HFCWO DMD DMD ALS 1 Bushby K, Finkel R, Birnkrant DJ et al : Diagnosis and man agement of Duchenne muscular dystrophy, part 1 : diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9 : 77 93, 2010 2 Bushby K, Finkel R, Birnkrant DJ et al : Diagnosis and management of Duchenne muscular dystrophy, part 2 : imple mentation of multidisciplinary care. Lancet Neurol 9 : 177 189, 2010 3 Finder JD, Birnkrant D, Carl J et al : Respiratory care of the patient with Duchenne muscular dystrophy. ATS consensus statement. Am J Respir Crit Care Med 170 : 456 465, 2004 4 personal communication by Dr. Tadayuki Ishihara 5 Mehta S, Hill NS : Noninvasive ventilation. Am J Respir Crit Care Med 163 : 540 577, 2001 6 Ward S, Chatwin M, Heather S et al : Randomized controlled trial of non invasive ventilation NIV for nocturnal hypoven tilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60 : 1019 1024, 2005 7 Bach JR : Management of patients with neuromuscular disease, Elsevier, Philadelphia, 2004, p289 296 8 Toussaint M, Chatwin M, Soudon P : Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency : clinical implications of 20 years published experience. Chri onic Respiratory Disease 4 : 167 177, 2007 9 Bach JR : A comparison of long term ventilatory support alternatives from the perspective of the patient and care giv er. Chest 104 : 1702 1706, 1993 10 Gomez Merino E, Bach JR : Duchenne muscular dystrophy : prolomgation of life by noninvasive respiratory muscle aids. Am J Phys Med Rehabil 81 : 411 415, 2002 11 Ambrosino N, Carpene N, Gherardi M : Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 34 : 444 451, 2009 12 Ishikawa Y, MIura T, Ishikawa Y et al : Duchenne muscular dystrophy : survival by cardio respiratory interventions. Neuromuscul Disord 21 : 47 51, 2011 13 Baydur A, Kanel G : Tracheobronchomalacia and tracheal hemorrage in patients with Duchenne muscular dystrophy recieving long term ventilation with uncuffed tracheosto mies. Chest 123 : 1307 1311, 2003 14 Bach JR : The prevention of ventilatory failure due to inade quate pump function. Respiratory Care 42 : 403 413, 1997 15 Toussaint M, Boltano LJ, Gathot V et al : Limits of effective cough augmentation techniques in patients with neuromus cular disease. Respir Care 54 : 359 366, 2009 16 Homnick DN : Mechanical insufflation exsufflation for airway mucus clearance. Respir Care 52 : 1296 1305, 2007 Vol. 30 No. 2 2013 212